AN

Ashwini Namdeo Satpute

Active Director Director DIN 11164663
DIN 11164663 First appointment Jun 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ashwini Namdeo Satpute

Data last updated:

Ashwini Namdeo Satpute is a Director at Arogyasadan Medical Private Limited (since 2025).

DIN 11164663
Primary Designation Director
First Appointment 21 Jun 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arogyasadan Medical Private Limited U86201PN2025PTC242560
Director21 Jun 2025Active

Directorship timeline

Open interactive timeline →
Arogyasadan Medical Private Limited
Premium access

Shareholding and investment profile for Ashwini Namdeo Satpute

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashwini Namdeo Satpute

Ashwini Namdeo Satpute currently holds 1 directorship: Arogyasadan Medical Private Limited (Director, since 21 Jun 2025).

Ashwini Namdeo Satpute was first appointed on 21 Jun 2025 as Director at Arogyasadan Medical Private Limited.

The current boards of Ashwini Namdeo Satpute's companies include Aarti Dhananjay Ware (Arogyasadan Medical Private Limited), Gayatri Manohar Badarkhe (Arogyasadan Medical Private Limited), Minal Thukaram Korade (Arogyasadan Medical Private Limited), Nikhil Dnyandev Satpute (Arogyasadan Medical Private Limited), Sneha Ramesh Bharad (Arogyasadan Medical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available